Qsemble Capital Management »

Crispr Therapeutics shares owned by Qsemble Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Qsemble Capital Management from 13F filings

Historical chart of Qsemble Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Qsemble Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Qsemble Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $369k 7.6k 48.64
2024-12-31 $695k 18k 39.36